Best GLP-1 for Self-Employed Workers in 2026: Cash-Pay, HSA, or Insurance?

The 30-second answer

The best GLP-1 for self-employed people in 2026 isn’t one medication — it’s the right access route for your situation. For most freelancers, contractors, and 1099 workers paying cash, Eden is the strongest starting point ($129 first month, $209/month after on the 3-month plan, with HSA/FSA cards accepted at checkout and no membership fee). If you want FDA-approved Wegovy, Zepbound, or Foundayo — and you have a marketplace plan worth checking first — start with Ro ($39 first month, then as low as $74/month with the annual prepay plan, plus a free insurance coverage checker).

Here’s the part most “best GLP-1” pages skip: per KFF’s June 2024 analysis of 2024 federally facilitated Marketplace formularies, about 1% of those Marketplace prescription drug plans covered Wegovy for weight loss, while 82% covered Ozempic — same molecule (semaglutide), but only when prescribed for type 2 diabetes. Translation: if you’re self-employed on a federally facilitated Marketplace plan and you’re chasing weight-loss-only Wegovy coverage, expect an out-of-pocket path.

We compared eight GLP-1 telehealth providers head-to-head on the things that actually matter for 1099 income: predictable pricing, HSA/FSA acceptance at checkout, cancellation friction, and what they show you before you pay. Here’s the route map.

Verified picks at a glance

Quick verdict: Eden wins for most cash-pay self-employed buyers. Ro wins when insurance is worth checking or you specifically want FDA-approved brand-name medication. The other picks below are for narrower fits.

Not for: If you have Medicare or Medicaid, this guide isn’t your starting point — see our Medicare GLP-1 guide instead. If you only want FDA-approved brand-name medication, skip the compounded picks and start with Ro or Sesame Care.

What we actually verified for this page

Here’s what we checked, when, and what still needs your own verification at checkout:

• Provider pricing — pulled directly from each provider’s pricing or checkout page on May 1–2, 2026
• HSA/FSA language — verified on each provider’s payment or FAQ page where disclosed (not all providers accept HSA/FSA cards)
• Insurance support — confirmed Ro’s coverage checker and concierge language on Ro’s official insurance page
• FDA-approved manufacturer pricing — pulled from NovoCare Pharmacy and LillyDirect official pages
• Tax framework — based on IRS Publication 502, IRS Publication 969, IRS guidance on weight-loss-related medical expenses, and IRS Form 7206 instructions
• ACA Marketplace coverage data — sourced from KFF’s June 2024 analysis of 2024 federally facilitated Marketplace formularies (state-run Marketplaces excluded)
• FDA regulatory standing — checked the FDA warning letter database; we disclose any open letters in the provider sections below

We did not purchase from each provider to test fulfillment, and we did not verify HSA/FSA card acceptance at checkout for every provider — Eden, SHED, Direct Meds, NovoCare, and LillyDirect have explicit HSA/FSA language; Enhance.MD’s FAQ states it does not accept HSA/FSA cards; Yucca’s FAQ states it does not provide itemized receipts or letters of medical necessity; Ro, Sesame Care, and MEDVi require checkout-level verification before assuming card acceptance.

We are not a medical authority, a tax authority, or your accountant. Verify with your prescriber, your tax professional, and your HSA administrator before acting on anything you read here.

Why “best GLP-1 for self-employed” is a different question than “best GLP-1”

Answer: Self-employed workers face a different set of rules than W-2 employees: no employer GLP-1 coverage, ACA Marketplace plans that almost never cover weight-loss medication (about 1% Wegovy coverage rate per KFF’s 2024 federally facilitated Marketplace analysis), and unpredictable monthly income that makes a $200–$400 recurring expense feel risky. Self-employed people also have tax-positioning levers — HSA contributions, the self-employed health insurance deduction, and the Schedule A medical-itemizing threshold — that change the effective net cost of a GLP-1.

When a Fortune 500 employee gets Zepbound, they often pay a $25 copay because their employer’s plan covers it. When you’re self-employed on a Bronze marketplace plan, your insurance pays $0 and you pay the full retail of $1,000+/month — unless you go cash-pay through a compounded telehealth provider or buy direct from the manufacturer through programs like NovoCare or LillyDirect.

Three things working against you:

1. About 1% of federally facilitated Marketplace prescription drug plans cover Wegovy for weight loss (KFF, 2024 federal data)
2. About 82% of those same plans cover Ozempic — same molecule (semaglutide), but only when prescribed for type 2 diabetes
3. Most self-employed workers don’t have access to employer HRAs, ICHRAs, or GLP-1 carve-outs

Three things working for you:

1. HSA contributions — if you have an HSA-eligible high-deductible health plan (HDHP — for 2026, at least $1,700 self-only or $3,400 family deductible, with out-of-pocket maximums not exceeding $8,500 self-only or $17,000 family), 2026 contribution limits are $4,400 self-only and $8,750 family. HSA contributions are deductible for federal income-tax purposes, grow tax-free, and qualified withdrawals (including for prescribed GLP-1s) are tax-free.
2. Self-employed health insurance deduction — an above-the-line deduction reported on Schedule 1, Line 17 (calculated using IRS Form 7206). Lowers your AGI even if you don’t itemize. Covers premiums, not the medication itself.
3. Schedule A itemized medical expense deduction — out-of-pocket medical costs above 7.5% of your AGI are deductible if you itemize. Most self-employed people won’t, but if you have a high-medical year, it can stack.

We’ll get into the dollar-for-dollar tax math further down. The headline: pick the access route first, then layer the tax work on top.

The 5 best GLP-1 providers for self-employed buyers, ranked

Answer: After comparing eight GLP-1 telehealth platforms on cash-pay pricing, HSA acceptance, cancellation flexibility, and medication menu, Eden is the best overall route for cash-pay self-employed buyers, Ro is the best route for FDA-approved brand-name medication and insurance help, MEDVi is a strong cash-pay alternative with one important regulatory disclosure, SHED is the best needle-free option, and Yucca Health is best for project-based income that needs payment flexibility.

The 12-month total cost comparison

Answer: Year 1 cash cost for compounded semaglutide programs ranges from roughly $1,800–$3,800/year depending on provider and dose. FDA-approved Wegovy or Zepbound through manufacturer self-pay programs varies significantly by drug, dose, refill timing, and promo windows. After layering HSA-paid medication and the self-employed health insurance deduction (for premiums), effective net cost can drop meaningfully for buyers in higher tax brackets.

The number that matters isn’t the first-month intro price. It’s what you actually pay over 12 months at the dose your prescriber settles on. This table assumes ongoing pricing at the dose listed; dose escalation, promo windows, and refill-timing requirements can move the actual number.

Pricing verified May 1–2, 2026 from each provider’s pricing page or NovoCare/LillyDirect official self-pay pages. Promo windows, dose escalation, and policy changes can move these numbers. The FDA-approved row totals depend heavily on dose, medication, promo window, refill timing, and whether telehealth membership fees are separate. Re-verify before purchase.

Three takeaways for self-employed buyers:

1. The cheapest first month is rarely the cheapest year. Enhance.MD Core looks great at $49 in month one, but adds up to roughly the same as Eden over 12 months. Yucca’s $146 starting price requires a 6-month commitment.
2. Membership-plus-medication math beats medication-only sometimes — but only when insurance helps. Ro’s $888 annual membership + medication is the best deal if your insurance covers the medication. If it doesn’t, Eden’s all-in $2,428 is cheaper than Ro’s membership + cash-pay LillyDirect/NovoCare medication for most buyers.
3. Brand-name pricing escalates with dose. A reader on Wegovy 0.25 mg pays $199 in months 1–2, but at the maintenance dose pays $349/month. A reader on Zepbound 2.5 mg pays $299/month, but at 10 mg pays $699/month (or $449 with the Journey 45-day refill window). Plan for the maintenance dose, not the starter dose.

Should you use insurance, HSA/FSA, or pay cash?

Answer: Always check insurance first if you have a marketplace plan (it’s free and takes minutes via Ro’s coverage checker), but don’t expect coverage for weight-loss-only Wegovy — only about 1% of federally facilitated Marketplace plans covered it per KFF’s 2024 data. Use HSA dollars when you have an HDHP and your prescriber documents the medication for a qualifying condition. Pay cash when predictability matters more than chasing coverage that probably won’t come through.

Path 1: Check insurance first if you have a marketplace plan

This is free. It takes 5 minutes. Do it before paying cash.

KFF’s June 2024 analysis of 2024 federally facilitated Marketplace plan formularies found:

• About 1% of those Marketplace prescription drug plans covered Wegovy (semaglutide for weight loss)
• About 82% covered Ozempic (same molecule, but FDA-approved for type 2 diabetes)

That gap tells you everything: insurers will cover semaglutide as a diabetes drug but rarely as a weight-loss drug. If you have type 2 diabetes, your odds change dramatically. If you don’t, expect denial — but check anyway because it’s free and there are sometimes coverage paths through obstructive sleep apnea (now an FDA-approved Zepbound indication) or cardiovascular disease (now an FDA-approved Wegovy injection indication).

State-run Marketplaces aren’t covered in the KFF analysis, so coverage there could differ. Either way, the fastest path to find out is Ro’s free GLP-1 Insurance Coverage Checker. They run the coverage check for you and produce a personalized report. No charge, no commitment.

Path 2: Use HSA/FSA dollars if you have an HDHP

If you have a high-deductible health plan (HDHP — for 2026, at least $1,700 self-only or $3,400 family deductible per IRS guidance), you can fund a Health Savings Account (HSA). 2026 HSA contribution limits:

• $4,400 for self-only coverage
• $8,750 for family coverage

HSA contributions made by self-employed people directly are deductible for federal income-tax purposes, grow tax-free, and qualified withdrawals (including for prescribed GLP-1s) are tax-free. Important caveat for self-employed people: unlike W-2 cafeteria-plan HSA contributions made through payroll, direct HSA contributions made by self-employed individuals generally do not reduce self-employment tax. Talk to your accountant before assuming SE tax savings.

The qualifying-condition rule: the medication has to be a qualified medical expense. Per IRS guidance, weight-loss treatment qualifies only when prescribed for a specific physician-diagnosed disease — obesity, diabetes, hypertension, heart disease. Cosmetic weight loss does not qualify.

For most telehealth GLP-1 prescriptions, this is straightforward — your prescriber can document obesity (BMI ≥ 30) or overweight with a comorbidity (BMI ≥ 27 with hypertension, sleep apnea, etc.) on the prescription note. If your HSA administrator asks for a Letter of Medical Necessity, ask your provider — most will issue one (Yucca is an exception per their FAQ; Enhance.MD does not accept HSA/FSA cards directly).

Which providers accept HSA/FSA at checkout (verified):

• Eden — yes, HSA/FSA cards accepted for most visits and prescriptions
• SHED — yes, accepted for medical prescription supplies, provider visits, and shipping
• Direct Meds — yes, with documentation provided
• NovoCare and LillyDirect — yes for FDA-approved medication
• Ro, Sesame, MEDVi — verify at checkout
• Yucca — accepts HSA/FSA cards but does not provide itemized receipts or LMNs (administrator may require these)
• Enhance.MD — does not accept HSA/FSA cards per their FAQ

Path 3: Pay cash when predictability beats chasing coverage

Pay cash when:

• Your insurance has confirmed it doesn’t cover GLP-1s for weight loss
• You don’t want to wait 3–6 weeks for prior authorization
• You want to start treatment now while your cash flow is good
• You can’t justify a higher-premium plan on the chance of GLP-1 coverage
• You’re comfortable evaluating compounded providers individually

For most self-employed buyers, this ends up being the path. Eden is the strongest first stop for compounded cash-pay because the pricing is transparent, HSA/FSA cards work at checkout, and there’s no membership fee layered on top.

Don’t buy a health plan just to cover Wegovy

Answer: Buying a more expensive marketplace plan in hopes of GLP-1 coverage is usually a worse deal than paying cash. Even Gold plans rarely cover weight-loss GLP-1s, and prior authorization, formulary changes, and deductibles can leave you paying the medication price anyway — on top of the higher premium.

This is the trap most “best GLP-1 for self-employed” pages won’t warn you about because there’s no affiliate revenue in talking you out of switching plans.

A typical scenario: You’re paying $400/month for a Bronze marketplace plan. You look at a Gold plan at $650/month thinking it’ll cover Wegovy. Even if it does (and it probably won’t — most marketplace plans of any tier exclude weight-loss medications), you’re paying $250 extra per month — that’s $3,000 a year — plus whatever the medication costs after deductible and coinsurance. Compare that to $2,428/year all-in on Eden cash-pay.

The exception: if you have type 2 diabetes, cardiovascular disease, or obstructive sleep apnea, the math changes. Those conditions create coverage pathways for Ozempic, Wegovy, or Zepbound that don’t exist for weight-loss-only prescriptions. In that case, talk to a broker before open enrollment.

The rule for everyone else: Run the cash-pay numbers against the higher-premium plan numbers including deductible and likely denial outcomes before switching plans. Most of the time, paying cash through a transparent provider beats trying to game the marketplace.

Compounded vs. FDA-approved: which makes sense for a self-employed budget?

Answer: Compounded semaglutide and tirzepatide programs typically run $129–$329/month, while FDA-approved Wegovy, Zepbound, or Foundayo through manufacturer self-pay programs run $149–$699/month depending on dose. Compounded medications are not FDA-approved finished drug products and have not been individually reviewed by the FDA for safety, effectiveness, or quality. The choice depends on your cost tolerance, your prescriber’s clinical judgment, and how much regulatory comfort you want.

Two terms first, before anything else:

FDA-approved medication means the FDA has reviewed the specific drug for safety, effectiveness, and quality. Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo, and Saxenda are FDA-approved.

Compounded medication is prepared by a state- or federally-licensed pharmacy. A 503A pharmacy fills individual patient-specific prescriptions; a 503B outsourcing facility produces in larger batches under FDA inspection. Compounded medications are not FDA-approved finished products. Whether a compounded GLP-1 is legal depends on the specific prescription, formulation, pharmacy, patient-specific documentation, and current FDA rules — not just on a provider marketing a different dose, route, or combination.

On the shortage situation: the FDA determined the tirzepatide injection shortage was resolved in late 2024 and the semaglutide injection shortage was resolved in 2025. The shortage-based enforcement discretion that allowed mass compounding ended in 2025. Compounded products that are “essentially copies” of commercially available semaglutide or tirzepatide are restricted under current FDA policy. Compounded GLP-1 telehealth offerings now generally emphasize specific formulations like alternative routes (sublingual, oral lozenges) or different concentrations.

When compounded fits a self-employed buyer

• Cost is the binding constraint and you’d rather pay $200–$300/month than not start
• A specific formulation (oral, sublingual, microdose) is appropriate per your prescriber
• You’re comfortable with the regulatory tradeoff and have read FDA’s compounded drug guidance
• You’re using a provider that names its compounding pharmacy and follows recognized standards (PCAB accreditation, USP 797 sterile compounding, USP 795 non-sterile compounding)

When FDA-approved fits a self-employed buyer

• You have any chance of insurance coverage (use Ro’s free checker)
• You want maximum HSA/FSA reimbursement defensibility
• You want the underlying clinical trial evidence (Wegovy STEP trials, Zepbound SURMOUNT trials, Foundayo ATTAIN trials)
• You want the medication’s full FDA-approved label (Wegovy now FDA-approved for cardiovascular risk reduction in obese adults with established CVD; Zepbound FDA-approved for moderate-to-severe obstructive sleep apnea)
• You have any complex medical history that makes regulatory consistency more important to you

The compliance line we hold: We do not describe compounded semaglutide or tirzepatide as “the same as,” “equivalent to,” or “FDA-evaluated like” Wegovy, Zepbound, or Foundayo. Compounded products may be compounded semaglutide or tirzepatide preparations, but they are not those FDA-approved medications and have not been individually reviewed by the FDA.

Can self-employed people deduct GLP-1 medications on their taxes?

Answer: Possibly, under specific conditions. GLP-1 medications can be a qualified medical expense if they’re prescribed for a diagnosed condition like obesity, type 2 diabetes, hypertension, or heart disease (not cosmetic weight loss), and either (a) paid through HSA/FSA dollars or (b) deducted on Schedule A if your unreimbursed medical expenses exceed 7.5% of your AGI and you itemize. You can’t double-count: HSA-paid expenses are not also Schedule A deductible.

Most self-employed people miss this conversation because their accountant doesn’t proactively raise it. A few minutes of math here can save real money.

The three tax levers a self-employed GLP-1 buyer can stack

Lever 1: HSA contributions (most powerful for most people)

• Requires an HSA-eligible HDHP (2026: at least $1,700 self-only or $3,400 family deductible)
• 2026 HSA contribution limits: $4,400 self-only / $8,750 family
• Direct contributions reduce federal income tax (and most state income taxes)
• Important caveat: direct HSA contributions by self-employed people generally do not reduce self-employment tax (W-2 cafeteria-plan HSA contributions can — yours don’t, unless your accountant has structured your business differently)
• Withdrawals for qualified medical expenses are tax-free

Lever 2: Self-employed health insurance deduction

• Above-the-line deduction reported on Schedule 1, Line 17 (calculated using IRS Form 7206)
• Doesn’t require itemizing
• Reduces AGI directly
• Covers your health insurance premiums, not the GLP-1 medication itself
• Not allowed in months you (or your spouse) had access to subsidized employer coverage

Lever 3: Schedule A itemized medical expense deduction

• Out-of-pocket medical above 7.5% of AGI
• Requires itemizing — and most self-employed people take the standard deduction (2026: $16,100 single / $32,200 married filing jointly)
• The medication itself counts here only if not paid through HSA/FSA

The tax stacking math (illustrative — not personalized advice)

These examples use federal income-tax effects only; state tax treatment varies. They do not assume self-employment tax savings on direct HSA contributions.

The headline: for most self-employed buyers, the HSA route saves more than itemizing. If you don’t have an HSA-eligible plan, the medication is essentially fully out-of-pocket — which makes provider selection (predictable pricing, cancellation flexibility, dose stability) much more important.

Talk to your accountant — but raise it yourself

Most accountants don’t proactively ask about GLP-1s. Bring it up:

1. “I’m paying $X/month for a prescribed GLP-1. Should we capture this anywhere?”
2. “I have an HDHP — would maxing my HSA be more efficient than itemizing?”
3. “If I have a high-medical year, can we make sure to capture all 12 months of GLP-1 costs?”

This section is informational, not tax advice. Consult a qualified tax professional before making decisions based on tax positioning.

What if your income drops mid-year? (The 1099 cash flow problem)

Answer: Self-employed income is rarely steady, and a $200–$400 recurring expense becomes risky during slow months. The four practical strategies: choose a provider with no annual lock-in, use BNPL strategically (Yucca offers Klarna/Affirm/Afterpay), front-load HSA contributions during high-income months, and verify each provider’s specific cancellation/pause terms before signing up so a slow month doesn’t trigger a charge you can’t reverse.

Strategy 1: Avoid annual prepay if your income is volatile

Annual prepay locks you in at lower per-month pricing but kills your flexibility. Ro’s annual plan brings membership down to as low as $74/month with annual plan paid upfront — great for steady-retainer consultants, but a problem if a major client churns.

For project-based income, monthly is safer. Eden’s monthly option ($149 first / $229 after) costs more per month than the 3-month plan but lets you stop without prepay regret.

Strategy 2: Use BNPL strategically (not as a default)

Yucca Health offers Klarna, Affirm, and Afterpay at checkout. Useful when a client invoice is delayed but your medication shipment is due. BNPL is a tool, not a strategy — missed payments hit your credit.

Strategy 3: Front-load HSA during high-income months

Front-load HSA contributions during high-income months and spend down during slow months. Keep a separate HSA balance roughly equal to 6–12 months of GLP-1 costs as a buffer.

Strategy 4: Know each provider’s actual cancellation and refund rules before you sign up

Generic “most providers allow pause” advice doesn’t help when your specific provider has a final-sale rule on shipped medication. Here’s what each provider’s published terms say:

This isn’t comprehensive — read each provider’s terms before you commit, especially before any annual prepay. Verification dates: provider terms reviewed May 1–2, 2026.

The hidden costs nobody puts on the comparison page

Answer: The advertised monthly price often hides shipping, labs, dose-change fees, refill fees, cancellation windows, and required commitments. Self-employed buyers who only compare the headline number can end up with a 12-month total that’s 30–50% higher than expected.

Use this checklist before you click “subscribe” on any GLP-1 program:

• First-month price (intro vs. ongoing)
• Ongoing monthly price after intro window expires
• Is medication included in the price, or separate?
• Is there a membership fee?
• Are labs required, and are they included?
• Is shipping included or separate?
• Does the price change when your dose increases?
• Is there a required commitment (2 months, 3 months, 6 months, annual)?
• What's the cancellation window — how soon before next billing?
• Refund policy on unused or shipped medication?
• Is the pharmacy named, and is it 503A or 503B?
• Is HSA/FSA accepted at checkout, or reimbursement only?
• Will the provider issue an itemized receipt or Letter of Medical Necessity?
• Does the provider operate in your state? (Verify at intake/checkout)
• Is there real prescriber support, or just chat?

Provider-specific friction examples (from each provider’s verified pages)

• Ro: Membership and medication are separate billing lines. $39 first month is membership only — medication is additional.
• Eden: Active orders cannot be canceled once sent to the pharmacy.
• SHED: HSA Store SHED listings reference a two-month minimum commitment with non-refundable payments.
• Yucca: That $146/month “starting at” price requires a 6-month plan; itemized receipts and LMNs are not provided per their FAQ.
• Enhance.MD: Does not accept HSA/FSA cards per their FAQ.
• MEDVi: FDA warning letter from February 20, 2026 — verify remediation status directly.

Real customer testimonials (with attribution)

Answer: We use only publicly-published, attributed testimonials about service experience — not as proof of medical outcomes. Each quote below includes the source and the provider’s own disclosure where applicable.

Required disclaimer: Testimonials reflect individual service experiences. They are not evidence of typical medical outcomes, medication safety, or weight-loss results. We may have an affiliate relationship with the providers mentioned.

How we picked these providers (methodology)

Answer: We scored eight GLP-1 telehealth providers on six factors weighted for self-employed buyers: predictable monthly cost (25%), no employer-insurance dependency (20%), HSA/FSA acceptance and documentation (15%), cancellation and commitment clarity (15%), clinical support and access (15%), and regulatory transparency (10%). We did not rank by lowest headline price.

What we did:

• Loaded each provider’s pricing or checkout page on May 1–2, 2026
• Pulled HSA/FSA language from each provider’s payment or FAQ page
• Verified Ro’s coverage checker and concierge language on Ro’s official insurance pages
• Cross-checked manufacturer self-pay pricing with NovoCare and LillyDirect official sources
• Checked the FDA warning letter database for any open letters against listed providers
• Reviewed IRS Publication 502, IRS Publication 969, and IRS Form 7206 instructions
• Pulled ACA Marketplace coverage data from KFF’s June 2024 analysis of 2024 federally facilitated Marketplace formularies

What we didn’t do:

• We did not purchase from each provider to test fulfillment
• We did not determine medical eligibility — that’s between you and a licensed clinician
• We did not verify insurance approval or reimbursement outcomes — those depend on your specific plan
• We did not include providers we couldn’t verify on pricing or HSA/FSA at the time of writing

If we removed every affiliate link from this page, would it still be the most useful resource for self-employed people researching GLP-1 access? That’s the test, and the answer needs to be yes.

Self-Employed GLP-1 Decision Tree

Answer: Start with the constraint that would make the wrong choice most expensive — FDA-approved-only, insurance check, predictable cash-pay, needle preference, or BNPL. The tree below routes you to the matching provider in under a minute.

1. 1. Do you only want FDA-approved brand-name medication (Wegovy, Zepbound, Foundayo, Ozempic)?

   • Yes → Start with Ro. Secondary: Sesame Care.
   • No → Continue to question 2.

2. 2. Do you have commercial or marketplace insurance worth checking before paying cash?

   • Yes → Run Ro’s free coverage checker first. It’s free.
   • No → Continue to question 3.

3. 3. Are you needle-averse?

   • Yes → Check SHED for lozenges, or Direct Meds for sublingual.
   • No → Continue to question 4.

4. 4. Is your income steady or project-based?

   • Steady → Eden 3-month plan for best price predictability.
   • Project-based / lumpy → Yucca with BNPL for cash flow flexibility.

5. 5. Do you want metabolic labs and a more clinical experience?

   • Yes → Enhance.MD (Core, Advanced, or Elite plan).
   • No → Stay with Eden, MEDVi, or Yucca depending on budget.

Frequently asked questions

The bottom line for self-employed GLP-1 buyers

The best GLP-1 for self-employed workers in 2026 isn’t a single medication — it’s the access route that fits your income, your insurance situation, and your willingness to pay cash for predictability over chasing coverage that probably won’t come.

For most self-employed cash-pay buyers, Eden is the strongest first option: transparent pricing, same price every dose, HSA/FSA at checkout, no membership fees stacking on top of medication cost. For self-employed people with marketplace insurance worth checking — or who specifically want FDA-approved Wegovy, Zepbound, or Foundayo — Ro is the better start because of the free coverage checker, the insurance concierge, and brand-name medication at LillyDirect/NovoCare-matched pricing.

Layer on the HSA tax lever if you have an HDHP (direct contributions reduce federal income tax even though they don’t reduce self-employment tax for most direct contributors), use the self-employed health insurance deduction for premiums, and keep an eye on Schedule A medical itemizing if you have a high-medical year. A $2,400 cash-pay year often comes out closer to $1,900 in net effective federal cost for buyers who can fund an HSA — and your accountant can fine-tune from there.

You don’t need an HR department to figure this out. You just need the right route.

Related guides on Weight Loss Provider Guide

• Highest-rated GLP-1 telehealth providers (general)
• GLP-1 providers that handle prior authorization
• HSA/FSA-eligible GLP-1 providers
• Cheapest FDA-approved GLP-1
• Compounded GLP-1 providers (503A)
• Oral and needle-free GLP-1 options
• 503B outsourcing facility providers
• Medicare and Medicaid GLP-1 coverage
• Cheapest GLP-1 without insurance
• Cheapest tirzepatide without insurance

Sources and verification

• KFF, “Costly GLP-1 Drugs Are Rarely Covered for Weight Loss by Marketplace Plans” (June 2024 analysis of 2024 federally facilitated Marketplace formularies)
• KFF, “Medicaid Coverage of and Spending on GLP-1s” (January 2026 update)
• IRS Topic 502, Medical and Dental Expenses
• IRS Publication 502, Medical and Dental Expenses
• IRS Publication 969, Health Savings Accounts and Other Tax-Favored Health Plans
• IRS Form 7206 instructions (Self-Employed Health Insurance Deduction)
• IRS FAQ on medical expenses related to nutrition, wellness, and general health
• IRS Revenue Procedure 2025-19 (2026 HSA/HDHP inflation-adjusted limits)
• IRS news release on 2026 inflation-adjusted standard deduction amounts
• HealthCare.gov self-employed coverage and Special Enrollment Period guidance
• HealthCare.gov HSA-eligible plan guidance
• FDA, “FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize”
• FDA Warning Letter Database (MEDVi LLC dba MEDVi, 721455, February 20, 2026)
• FDA news release on Foundayo (orforglipron) approval
• Ro official “How Our Weight Loss Program Works,” GLP-1 Insurance Coverage Checker, and Zepbound KwikPen pages
• Eden official treatment, pricing, FSA/HSA, and cancellation/refund pages
• MEDVi official program pricing and testimonial pages
• Sesame Care official online weight-loss program pricing
• SHED (ShedRx) GLP-1 lozenges product and FSA/HSA pages; HSA Store SHED listing terms
• Yucca Health official GLP-1 plan pricing, FAQ, and terms pages
• Enhance.MD official Core, Advanced, and Elite plan pages and FAQ
• Direct Meds official pricing and HSA/FSA acceptance page
• NovoCare Pharmacy official Wegovy self-pay pricing pages
• LillyDirect official Foundayo and Zepbound self-pay pricing and Self Pay Journey Program terms
• Centers for Medicare & Medicaid Services (CMS) official Medicare GLP-1 Bridge program guidance

Pricing, policies, and regulatory information were verified May 1–2, 2026. We re-verify monthly and update this page on a quarterly schedule, with hard refresh dates calendared to manufacturer promo expirations and FDA policy changes. Please re-check provider pages directly before purchasing — pricing can shift without notice.